Title:
結核菌シャペロニン６０．１ペプチドおよびその使用
Document Type and Number:
Japanese Patent JP7252895
Kind Code:
B2
Abstract:
The present invention relates to novel peptides derivable from the polypeptide chaperonin 60.1 and to their use in medicine, such as for the prevention and/or treatment of inflammatory conditions.
Inventors:
Lightfoot, Andrew
Cooper, nicolas
Cooper, nicolas
Application Number:
JP2019538337A
Publication Date:
April 05, 2023
Filing Date:
January 11, 2018
Export Citation:
Assignee:
Revolo Biotherapeutics Limited
International Classes:
C07K7/08; A61K31/522; A61K31/573; A61K38/10; A61K38/19; A61K39/395; A61K45/00; A61P1/04; A61P3/10; A61P5/50; A61P7/00; A61P7/04; A61P7/06; A61P7/10; A61P9/10; A61P11/00; A61P11/02; A61P11/06; A61P11/14; A61P13/12; A61P17/00; A61P17/04; A61P19/02; A61P19/04; A61P21/04; A61P25/00; A61P27/02; A61P29/00; A61P31/10; A61P33/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; C07K14/35
Domestic Patent References:
| JP2014532395A | ||||
| JP2013510094A | ||||
| JP2007503382A | ||||
| JP2010502765A |
Other References:
Angiogenesis, 2011, Vol.14, pp.431-442
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office